| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |